Updox Achieves Complete DirectTrust.org/EHNAC HISP, RA, and CA Accreditations for Its Direct Secure Messaging

Dublin, Ohio, June 24, 2014 -- Updox, the industry leader for physician connectivity and CRM solutions for health care, announced the organization achieved full accreditation with the Direct Trusted Agent Accreditation Program (DTAAP) as a Health Information Service Provider/Registration Authority/Certificate Authority (HISP/RA/CA) from DirectTrust.org and the Electronic Healthcare Network Accreditation Commission (EHNAC). Accreditation by EHNAC certifies that an organization’s Direct secure messaging services meet HIPAA and HITECH requirements, industry standards, and Direct Project regulations. Updox is one of just 12 organizations having received each of the three HISP/RA/CA accreditations from EHNAC and DirectTrust.org.

EHNAC is the premier accreditation authority promoting standards that support interoperability, stakeholder trust, regulatory compliance, quality service, innovation, and open competition within healthcare. EHNAC evaluated Updox business, privacy, security, and confidentiality practices, as well as its technical performance and Direct exchange resources. By earning this meaningful third-party accreditation, Updox demonstrates to customers it provides the highest level of quality, compliance, industry compatibility and enhanced partner relationships.

“What does accreditation mean for Updox customers? EHNAC accreditation provides another level of value to the Updox Direct Network (UDN), the largest in the nation built on Direct, with more than 45 electronic health record (EHR) vendors and representing 140,000 physicians,” said Michael Morgan, chief executive officer, Updox. “Customers within the UDN can easily and securely exchange email with anyone else who is also EHNAC certified. Securely exchanging of health information is an essential component of improving the speed, safety, quality and cost of patient care.”

EHNAC is a self-governing standards development organization (SDO) that certifies entities involved in the electronic exchange of healthcare-related data, including HIEs, e-prescribers, and medical billers. The accreditation process includes an application, a self-assessment and a site visit to the organization home office and data centers.

“Endorsed by the Office of the National Coordinator for Health Information Technology (ONC), the Direct Trusted Agent Accreditation Program ensures that organizations like Updox establish and uphold a superior level of trust for their stakeholders,” says Lee Barrett, executive director, EHNAC. “The need in the marketplace for guidance and accountability in health information exchange is undeniable, and we applaud Updox’s commitment to the highest standards in privacy, security and confidentiality.”

About DirectTrust.org
DirectTrust.org is a non-profit, competitively neutral, self-regulatory entity created by and for participants in the Direct community, including HISPs, CAs and RAs, doctors, patients, and vendors, and supports both provider-to-provider as well as patient-to-provider Direct exchange. The goal of DirectTrust.org is to develop, promote and, as necessary, help enforce the rules and best practices necessary to maintain security and trust within the Direct community, consistent with the HITECH Act and the governance rules for the NwHIN established by ONC.

DirectTrust.org is committed to fostering widespread public confidence in the Direct exchange of health information. To learn more, visit http://www.directtrust.org.

About EHNAC
The Electronic Healthcare Network Accreditation Commission (EHNAC) is a voluntary, self-governing standards development organization (SDO) established to develop standard criteria and accredit organizations that electronically exchange healthcare data. These entities include electronic health networks, payers, financial services firms, health information exchanges, medical billers, outsourced services, e-prescribing solution providers and direct trusted agents.

EHNAC was founded in 1993 and is a tax-exempt 501(c)(6) nonprofit organization. Guided by peer evaluation, the EHNAC accreditation process promotes quality service, innovation, cooperation and open competition in healthcare. To learn more, visit http://www.ehnac.org or contact info(at)ehnac(dot)org. Connect with EHNAC on Twitter, YouTube, LinkedIn and Facebook.

About Updox
Providing Customer Relationship Management (CRM) for health care, Updox is the industry leading Physician Connectivity Platform. More than 45 electronic health record (EHR) vendors, representing 140,000 physicians, selected Updox as their Health Information Service Provider (HISP) of choice to be a part of the Updox Direct Network (UDN). With our CRM solutions, independent medical practices can easily manage communications from one inbox, streamline physician relationships, drive collaboration with partners and engage patients – all integrated with the practice’s existing EHR. Practices benefit through improved relationships with patients and other providers, increased revenues, reduced costs, and enhanced business efficiencies.

Updox services are available directly to independent physicians or through partnerships with EHR vendors to help practices run more efficiently, increase revenues and offer patients a more satisfying experience interacting with their providers where they are treated like customers and not numbers. More than 30,000 members have joined Updox to change how medical practices collaborate and share information.

Find out what Updox can do for you. Visit http://www.updox.com, follow us on Twitter, like us on Facebook, connect with us on LinkedIn, watch us on YouTube or join our Google+ circle.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.